KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.
Santagata S, Trotta AM, D'Alterio C, Napolitano M, Rea G, Di Napoli M, Portella L, Ieranò C, Guardascione G, Coppola E, Caux C, Dubois B, Boyle HJ, Carles J, Rossetti S, Azzaro R, Feroce F, Perdonà S, Fordellone M, Bello AM, Califano D, Chiodini P, Pignata S, Scala S.
Santagata S, et al. Among authors: coppola e.
Clin Cancer Res. 2024 Oct 15;30(20):4755-4767. doi: 10.1158/1078-0432.CCR-24-0729.
Clin Cancer Res. 2024.
PMID: 39167621
Free PMC article.